Companies In the News
Authors:
Date:
PRNewswire: March 14, 2017 – SAN DIEGO, CA, U.S.A. – OncoSec Medical Incorporated (“OncoSec”) (NASDAQ: ONCS), a company developing DNA-based intratumoral cancer immunotherapies, announced today that they have entered into a technology access program (TAP) agreement with Inhibrx, LP, a privately…
Authors:
Date:
Business Wire: October 24, 2016 – STOCKHOLM, Sweden – Braeburn Pharmaceuticals and Camurus (STO: CAMX) today announced the expansion of their collaboration and license agreement from 2014 to include buprenorphine combination products. The first drug candidate within the expanded scope (CAM2058) is…
Authors:
Date:
PRNewswire: September 1, 2016 – MISSISSAUGA, Ontario, Canada – Crescita Therapeutics Inc. (TSX: CTX) (Crescita or the company), a drug development company that owns topical products for use in the treatment of medical conditions related to dermatology and pain, today announced that it has acquired…
Authors:
Date:
Business Wire: August 31, 2016 – AUSTIN, TX, U.S.A. – Caisson Biotech, LLC, has engaged Pickwick Capital Partners, LLC (member FINRA/SIPC), to assist in the sale of the HEPtune® drug-delivery platform. The proprietary platform centers on the use of a naturally occurring sugar polymer, heparosan,…
Authors:
Date:
PRNewswire: August 29, 2016 – STANS, Switzerland, Aug. 29, 2016 – NLS Pharma Group (NLS) announced today that it has initiated enrollment for its “Double-Blind Placebo-Controlled Phase II Study to Determine the Efficacy, Safety, Tolerability and Pharmacokinetics of a Controlled Release (CR)…
Authors:
Date:
PRNewswire: August 25, 2016 – WAYNE, PA, U.S.A. – Egalet Corporation (Nasdaq: EGLT) (“Egalet”), a fully integrated specialty pharmaceutical company focused on developing, manufacturing, and commercializing innovative treatments for pain and other conditions, today announced that researchers will…
